Industry

Holland Foundation looks to expand vision-saving transplants

Healio Optometry4h ago1 min read

Edward J. Holland, MD, cofounded the Holland Foundation for Sight Restoration because he knew he had a good idea, but that idea just was not catching on.Holland pioneered the Cincinnati Protocol of ocular surface stem cell transplantation by borrowing from renal transplant specialists and using preoperative testing of donors and recipients and full dosing of long-term systemic immunosuppression to prevent rejection. With this approach of managing ocular surface stem cells, he was able to significantly improve the outcomes of these procedures, which had been abandoned by most corneal surgeons

Read full article on Healio Optometry

AI Summary

Quick Take

Dr. Edward J. Holland established the Holland Foundation for Sight Restoration to promote the Cincinnati Protocol, a specialized ocular surface stem cell transplantation method. By adapting systemic immunosuppression strategies from renal transplantation, the protocol significantly improves success rates for procedures that many corneal surgeons had previously abandoned due to high rejection rates.

Why It Matters

Ocular surface stem cell transplants have historically been plagued by failure because the eye's immune environment was often poorly managed. Dr. Holland’s approach shifts the paradigm by treating these cases with the same rigor as organ transplants, utilizing full-dose systemic immunosuppression and rigorous preoperative testing. This offers a viable pathway for patients with severe corneal blindness who were previously considered untreatable, though it requires a multidisciplinary mindset that has been slow to gain widespread adoption in the ophthalmic community.

Key Details

The Cincinnati Protocol utilizes preoperative testing of both donors and recipients to ensure better compatibility.
Long-term, full-dose systemic immunosuppression is employed to prevent the rejection of transplanted ocular surface stem cells.
The protocol was developed by adapting successful strategies used in renal transplantation.
The Holland Foundation for Sight Restoration was cofounded to expand the reach of this technique after it failed to gain traction through traditional channels.
The approach aims to revitalize a field of surgery that many corneal specialists had previously abandoned due to poor outcomes.

Practice Implications

Clinicians managing patients with end-stage ocular surface disease or severe limbal stem cell deficiency should consider that stem cell transplantation can be successful when paired with systemic immunosuppression. Patients who were previously told they were not candidates for surgery may benefit from referral to specialists utilizing the Cincinnati Protocol.

Who's Affected

Corneal SurgeonsOphthalmologistsAnterior Segment SpecialistsPatients with Limbal Stem Cell Deficiency

Evidence StrengthModerate

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.